Jan-Eric Österlund

Jan-Eric Österlund is currently Chairman at Stril AB, Investment AB Skrinet, and Isofol Medical AB (since 2024).
He is Vice Chairman at The Lutheran Council of Great Britain, Independent Director at Dicot Pharma AB (since 2023), Director at Opulentia S.A., and Professor at Stockholm School of Economics (since 1970).
Former positions include President & Chief Executive Officer at Masonite AB (1978–1982), Chairman at HemoCue AB (1988–1992), Munksjö AB (1980–1985), Tigran Technologies AB (2002–2011), Scandcap AB (2012–2015), and Isofol Medical AB (2012–2018).
Director roles were held at ENKAM Pharmaceuticals A (2003–2018), Perstorp AB, Independent Leasing Ab (1992), Egalet Ltd., and Indigo AB (1999).
Executive Vice President at Studsvik Nuclear AB (1978).
Education includes graduate studies at Chalmers University of Technology and undergraduate studies at the University of Uppsala.